XZP-3287

· Sihuan Pharmaceutical Holdings Group Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XZP-3287, covering 2024-05-24 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer [Phase 3]